• Profile
Close

Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis

International Journal of Infectious Diseases Feb 12, 2021

Magalhães A, Carvalho LP, Costa R, et al. - The accuracy of anti-Leishmania IgG and IgG subclasses in differentiating clinical forms of American tegumentary leishmaniasis (ATL) was determined, and the relationship between antibodies levels with cytokine production and severity of ATL was examined. Researchers examined IgG and subclasses of IgG to soluble Leishmania antigen, as well cytokine levels in supernatants of mononuclear cells by ELISA among 40 cutaneous leishmaniasis (CL), 20 mucosal leishmaniasis (ML), 20 disseminated leishmaniasis (DL) patients and 20 individuals with subclinical L. braziliensis infection (SC). Overall 95%, 95% and 100% of CL, ML and DL patients, respectively, had detection of IgG. As per findings, high Anti-Leishmania IgG and IgG2 levels characterize DL, and while there was correlation of IgG with pro-inflammatory cytokines and direct correlation of IgG2 with number of lesions.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay